A Phase III Study Evaluate the Efficacy and Safety of BAT1406 and Humira
NCT04135508 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 554
Last updated 2019-10-22
Summary
A Phase III Study Evaluate the Efficacy and Safety of BAT1406 and Humira
Conditions
Interventions
- DRUG
-
BAT1406
40mg/0.8ml
- DRUG
-
40mg/0.8ml
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Jieruo Gu, Doctor · Third Affiliated Hospital, Sun Yat-Sen University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 16 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-12-13
- Primary Completion
- 2018-03-22
- Completion
- 2018-05-31
More Related Trials
-
Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid Arthritis
NCT02640612 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized, Double-blind, Single-dose, Two-arm Parallel Study to Compare the Pharmacokinetics and Safety of BAT1806 Prefilled Subcutaneous Injection With RoActemra® in Healthy Chinese Male Subjects
NCT05968508 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Study to Evaluate the Pharmacokinetics of BAT1806 vs Actemra® in Healthy Subjects
NCT03606876 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy
NCT00124982 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Comparing SB5 to Humira® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy
NCT02167139 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Clinical Study of Pharmacokinetics, Tolerance and Safety of BCD-057 and Humira in Healthy Volunteers
NCT02395055 ·Status: COMPLETED ·Phase: PHASE1
-
Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)
NCT01004432 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Effectiveness and Effect on Quality of Life and Work Productivity of Humira in Patients With Psoriatic Arthritis in Clinical Routine
NCT01078610 ·Status: WITHDRAWN
-
A Study of the Safety and Efficacy of Golimumab in Subjects With Active Ankylosing Spondylitis
NCT00265083 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Adalimumab (Humira®) Therapy on Selected Health Care Resource Utilization and Sick Leave in Patients With Ankylosing Spondylitis in Clinical Practice
NCT01754727 ·Status: COMPLETED
-
A Safety and Efficacy Study for Infliximab (Remicade) With Methotrexate in Patients With Early Rheumatoid Arthritis
NCT00236028 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 2 Study For Patients With A Physician's Diagnosis Of Rheumatoid Arthritis
NCT00550446 ·Status: COMPLETED ·Phase: PHASE2
-
Study Of PF-06410293 And Adalimumab In Healthy Subjects (REFLECTIONS B538-01)
NCT01870986 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Study of BAT1806 to RoActemra® in Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate
NCT03830203 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS)
NCT03502616 ·Status: COMPLETED ·Phase: PHASE3
-
Optimization of Treatment With Adalimumab (Humira)
NCT01585064 ·Status: COMPLETED
-
Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid Arthritis
NCT02744755 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis
NCT06201416 ·Status: RECRUITING ·Phase: PHASE1
-
Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis
NCT01142726 ·Status: COMPLETED ·Phase: PHASE3
-
A Study on Pharmacokinetics and Safety of BAT2506 Injection Versus Simponi®
NCT05332730 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02).
NCT02480153 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in Moderate to Severe Rheumatoid Arthritis
NCT01710358 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Efficacy, Safety and Tolerability of ACZ885 in Patients With Rheumatoid Arthritis
NCT00554606 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Abatacept in Patients With Early Rheumatoid Arthritis
NCT02504268 ·Status: COMPLETED ·Phase: PHASE3
-
A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate
NCT00847613 ·Status: COMPLETED ·Phase: PHASE3